• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃德蒙顿精神疾病流行病学。重度抑郁症。

Epidemiology of psychiatric disorders in Edmonton. Major depressive disorder.

作者信息

Spaner D, Bland R C, Newman S C

机构信息

Alberta Hospital, Edmonton, Canada.

出版信息

Acta Psychiatr Scand Suppl. 1994;376:7-15.

PMID:8178688
Abstract

A random sample of 3258 adult household residents of Edmonton, Alberta, Canada, were interviewed by trained lay interviewers, using the Diagnostic Interview Schedule (DIS), which generated DSM-III diagnosis data. This paper reports results for major depressive disorder (MDD). MDD was found to affect women more than men by a ratio of nearly 2 to 1. The lifetime prevalence rate for both sexes combined was 8.6%. The period prevalence rates for both sexes combined were 3.2% and 4.6%, for six month and one year, respectively. The presence of a recurrent Major Depressive Disorder was associated with an increased risk of substance abuse, panic disorder and dysthymia, whereas a single major depressive episode was not associated with increased comorbidity.

摘要

加拿大艾伯塔省埃德蒙顿市3258名成年家庭居民的随机样本,由经过培训的非专业访谈员使用诊断访谈表(DIS)进行访谈,该访谈表生成了《精神疾病诊断与统计手册》第三版(DSM - III)的诊断数据。本文报告了重度抑郁症(MDD)的研究结果。发现MDD对女性的影响大于男性,比例接近2比1。男女合并的终生患病率为8.6%。男女合并的六个月和一年期间患病率分别为3.2%和4.6%。复发性重度抑郁症的存在与物质滥用、惊恐障碍和心境恶劣障碍的风险增加相关,而单次重度抑郁发作与共病增加无关。

相似文献

1
Epidemiology of psychiatric disorders in Edmonton. Major depressive disorder.埃德蒙顿精神疾病流行病学。重度抑郁症。
Acta Psychiatr Scand Suppl. 1994;376:7-15.
2
Epidemiology of psychiatric disorders in Edmonton. Panic disorder.埃德蒙顿精神疾病流行病学。惊恐障碍。
Acta Psychiatr Scand Suppl. 1994;376:45-53.
3
Epidemiology of psychiatric disorders in Edmonton. Phobic disorders.埃德蒙顿精神疾病流行病学。恐惧症
Acta Psychiatr Scand Suppl. 1994;376:36-44.
4
Epidemiology of psychiatric disorders in Edmonton. Obsessive-compulsive disorder.埃德蒙顿精神疾病流行病学。强迫症。
Acta Psychiatr Scand Suppl. 1994;376:24-35.
5
Epidemiology of psychiatric disorders in Edmonton. Mania.埃德蒙顿精神疾病流行病学。躁狂症。
Acta Psychiatr Scand Suppl. 1994;376:16-23.
6
Epidemiology of psychiatric disorders in Edmonton. Antisocial personality disorders.埃德蒙顿精神疾病流行病学。反社会人格障碍。
Acta Psychiatr Scand Suppl. 1994;376:63-70.
7
Epidemiology of psychiatric disorders in Edmonton. Drug abuse and dependence.埃德蒙顿精神疾病流行病学。药物滥用与依赖。
Acta Psychiatr Scand Suppl. 1994;376:54-62.
8
Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.万塔抑郁症研究中接受精神科护理的DSM-IV重度抑郁症患者当前的精神疾病共病情况。
J Clin Psychiatry. 2002 Feb;63(2):126-34.
9
Incidence of mental disorders in Edmonton: estimates of rates and methodological issues.埃德蒙顿精神障碍的发病率:发病率估计及方法学问题
J Psychiatr Res. 1998 Sep-Oct;32(5):273-82. doi: 10.1016/S0022-3956(98)00011-9.
10
Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.边缘型人格障碍患者中轴I和轴II共病的性别差异。
Psychopathology. 2009;42(4):257-63. doi: 10.1159/000224149. Epub 2009 Jun 12.

引用本文的文献

1
Exercise therapy improves aerobic capacity of inpatients with major depressive disorder.运动疗法可改善住院抑郁症患者的有氧能力。
Brain Behav. 2016 Apr 22;6(6):e00469. doi: 10.1002/brb3.469. eCollection 2016 Jun.
2
The Association between Alcohol Dependence and Depression before and after Treatment for Alcohol Dependence.酒精依赖治疗前后酒精依赖与抑郁之间的关联
ISRN Psychiatry. 2012 Jan 26;2012:482802. doi: 10.5402/2012/482802. Print 2012.
3
Predisposition locus for major depression at chromosome 12q22-12q23.2.位于12号染色体q22 - 12q23.2区域的重度抑郁症易感基因座。
Am J Hum Genet. 2003 Dec;73(6):1271-81. doi: 10.1086/379978. Epub 2003 Nov 5.
4
Neurochemical and metabolic aspects of antidepressants: an overview.抗抑郁药的神经化学和代谢方面:综述
J Psychiatry Neurosci. 2000 Nov;25(5):481-96.
5
Sertraline. A pharmacoeconomic evaluation of its use in depression.舍曲林。其用于治疗抑郁症的药物经济学评价。
Pharmacoeconomics. 1996 Oct;10(4):409-31. doi: 10.2165/00019053-199610040-00009.
6
Fluoxetine. A pharmacoeconomic review of its use in depression.氟西汀。对其用于治疗抑郁症的药物经济学综述。
Pharmacoeconomics. 1998 May;13(5 Pt 1):543-61. doi: 10.2165/00019053-199813050-00007.
7
Paroxetine. A pharmacoeconomic evaluation of its use in depression.帕罗西汀。对其在抑郁症治疗中应用的药物经济学评估。
Pharmacoeconomics. 1995 Jul;8(1):62-81. doi: 10.2165/00019053-199508010-00008.